Feed Preview

Immunosuppression

Immunosuppression diagram by ibreakstock, Shutterstock
ibreakstock, Shutterstock

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Top 20 most recent papers
Gastroenterology

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

GastroenterologyFebruary 25, 2020
William J SandbornPeter D R Higgins
5
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Use of Biomarkers to Improve Immunosuppressive Drug Development and Outcomes in Renal Organ Transplantation: A Meeting Report

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant SurgeonsFebruary 25, 2020
Roslyn B MannonStephen R Karpen
4
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons

The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant SurgeonsFebruary 25, 2020
Katelynn Madill-ThomsenPhilip F Halloran
Disease Models & Mechanisms

Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis

Disease Models & MechanismsFebruary 26, 2020
Lynda AoudjehaneFilomena Conti
Journal of the American Academy of Dermatology

Integrated Safety Analysis: Frequency of Urinary Tract Infections in Patients with Psoriasis Treated with Ixekizumab

Journal of the American Academy of DermatologyFebruary 25, 2020
Saxon D SmithChristopher Schuster
Transplant Infectious Disease : an Official Journal of the Transplantation Society

BK-Polyomavirus Nephropathy with Systemic Viral Spread: Whole Genome Sequencing Data from a Fatal Case of BKPyV Infection

Transplant Infectious Disease : an Official Journal of the Transplantation SocietyFebruary 25, 2020
Sanjeet RoyVolker Nickeleit
ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs

Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices

ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal OrgansFebruary 27, 2020
Lauren K TrubyVeli K Topkara
Seminars in Immunopathology

The immunology of other mycobacteria: M. ulcerans, M. leprae

Seminars in ImmunopathologyFebruary 27, 2020
Katharina RöltgenCharlotte Avanzi
Transplantation

Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma

TransplantationFebruary 25, 2020
Raphael P H MeierThierry Berney
2
Transplantation Direct

Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients

Transplantation DirectFebruary 26, 2020
Anthony J HennesArjang Djamali
3
Food and Waterborne Parasitology

Elevated incidence of alveolar echinococcosis in immunocompromised patients

Food and Waterborne ParasitologyFebruary 26, 2020
A LachenmayerG Beldi
Journal for Immunotherapy of Cancer

On the mechanism of anti-CD39 immune checkpoint therapy

Journal for Immunotherapy of CancerFebruary 27, 2020
David AllardJohn Stagg
Food and Waterborne Parasitology

Surgical treatment strategies for hepatic alveolar echinococcosis

Food and Waterborne ParasitologyFebruary 26, 2020
L A SalmG Beldi
Heart, Lung & Circulation

Adherence to Cardiac Medications in Patients With Atrial Fibrillation: A Pilot Study

Heart, Lung & CirculationFebruary 25, 2020
Adrienne PaclebRobyn Gallagher
Auris, Nasus, Larynx

The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC

Auris, Nasus, LarynxFebruary 25, 2020
Toshimitsu OhashiYatsuji Ito
1
Journal of Neurology, Neurosurgery, and Psychiatry

Rituximab in AChR subtype of myasthenia gravis: systematic review

Journal of Neurology, Neurosurgery, and PsychiatryFebruary 27, 2020
Vincenzo Di StefanoCarmelo Rodolico

See more papers from this feed

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.


Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immuno-Oncology

Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

Tumor Vaccines

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

© 2020 Meta ULC. All rights reserved
/feed-previews/immunosuppression/ab4e10f5-bb3e-4c08-b1e2-ee814d7ac025